EDIT vs VRTX
EDIT 与 VRTX 的估值与基本面并排对比(公开数据)。
关键统计
| 指标 | EDITEditas Medicine, Inc. | VRTXVERTEX PHARMACEUTICALS INC / MA |
|---|---|---|
| 市值 | $258.47M | $119.40B |
| 市盈率(TTM) | — | 27.9 |
| 市净率 | — | 6.17 |
| 市销率 | 6.4x | 9.9x |
| 营收 | — | $12.22B(TTM) |
| 营收同比增长 | 25.4% | 8.9% |
| 净利润 | — | $4.34B(TTM) |
| 净利同比增长 | 32.5% | 838.1% |
| 每股收益(稀释) | — | $16.85(TTM) |
| 息税前利润率 | -394.9% | 34.8% |
| 净资产收益率 | -3631.1% | 20.4% |
| 投入资本回报率 | — | 25.4% |
| 一年总回报 | +8.0% | +1.8% |
数据来自 SEC 文件 · 仅供参考 · 非投资建议
1 万美元的成长:EDIT vs VRTX
| 指标 | EDIT | VRTX |
|---|---|---|
| 期末价值 | $767 | $59.2K |
| 总回报 | -92.3% | +492.2% |
| 年化收益 (CAGR) | -22.0% | +18.8% |
| 波动率 | 83.4% | 33.0% |
| 夏普比率 | 0.06 | 0.57 |
| 索提诺比率 | 0.09 | 0.84 |
| 最大回撤 | -98.9% | -41.6% |
基于 2600 个共同交易日,2016-03-31 → 2026-08-03 · 无风险利率 3.91%(当前短端国债,全程恒定)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
相关对比
数据延迟 · 公开数据 · 仅供参考 · 非投资建议(本页不评判孰优孰劣)